239.53
Overview
News
Price History
Option Chain
Financials
Why HUM Down?
Discussions
Forecast
Dividend History
Humana Inc stock is traded at $239.53, with a volume of 1.18M.
It is up +0.66% in the last 24 hours and up +34.70% over the past month.
Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
See More
Previous Close:
$237.96
Open:
$237.93
24h Volume:
1.18M
Relative Volume:
0.60
Market Cap:
$28.76B
Revenue:
$137.20B
Net Income/Loss:
$1.15B
P/E Ratio:
25.63
EPS:
9.3439
Net Cash Flow:
$1.27B
1W Performance:
+4.27%
1M Performance:
+34.70%
6M Performance:
-9.59%
1Y Performance:
-6.69%
Humana Inc Stock (HUM) Company Profile
Name
Humana Inc
Sector
Industry
Phone
(502) 580-1000
Address
101 E. MAIN STREET, LOUISVILLE, KY
Compare HUM vs UNH, CVS, ELV, CI
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
HUM
Humana Inc
|
239.53 | 28.57B | 137.20B | 1.15B | 1.27B | 9.3439 |
|
UNH
Unitedhealth Group Inc
|
363.87 | 336.72B | 449.71B | 12.81B | 19.67B | 13.24 |
|
CVS
Cvs Health Corp
|
80.69 | 105.10B | 402.11B | 1.73B | 7.81B | 1.3835 |
|
ELV
Elevance Health Inc
|
369.07 | 80.76B | 200.42B | 5.24B | 6.45B | 23.50 |
|
CI
Cigna Group
|
275.66 | 73.90B | 278.13B | 6.74B | 7.66B | 23.60 |
Humana Inc Stock (HUM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-12-26 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Feb-02-26 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jan-07-26 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-05-25 | Upgrade | Jefferies | Hold → Buy |
| Oct-14-25 | Initiated | Goldman | Sell |
| Sep-22-25 | Initiated | Evercore ISI | In-line |
| May-01-25 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Nov-06-24 | Upgrade | BofA Securities | Underperform → Neutral |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Oct-08-24 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Oct-07-24 | Downgrade | Jefferies | Buy → Hold |
| Oct-07-24 | Downgrade | TD Cowen | Buy → Hold |
| Oct-03-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Oct-02-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Oct-02-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Oct-02-24 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jun-26-24 | Initiated | Piper Sandler | Overweight |
| Jun-24-24 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-02-24 | Downgrade | BofA Securities | Buy → Neutral |
| Mar-22-24 | Initiated | Raymond James | Mkt Perform |
| Mar-13-24 | Downgrade | Argus | Buy → Hold |
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Jan-26-24 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jan-25-24 | Downgrade | Deutsche Bank | Buy → Hold |
| Dec-12-23 | Upgrade | Argus | Hold → Buy |
| Nov-08-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-07-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-23-23 | Downgrade | Argus | Buy → Hold |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-13-22 | Upgrade | Goldman | Neutral → Buy |
| Oct-26-22 | Upgrade | Deutsche Bank | Hold → Buy |
| Sep-20-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jun-17-22 | Initiated | Loop Capital | Buy |
| May-27-22 | Initiated | Bernstein | Mkt Perform |
| Apr-13-22 | Upgrade | UBS | Neutral → Buy |
| Jan-06-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-16-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-14-21 | Initiated | Goldman | Neutral |
| Nov-04-21 | Reiterated | Barclays | Overweight |
| Nov-04-21 | Reiterated | Credit Suisse | Outperform |
| Nov-04-21 | Reiterated | Morgan Stanley | Overweight |
| Nov-04-21 | Reiterated | Oppenheimer | Outperform |
| Nov-04-21 | Reiterated | RBC Capital Mkts | Outperform |
| Sep-27-21 | Initiated | SVB Leerink | Outperform |
| Sep-10-21 | Initiated | Cowen | Outperform |
| Sep-09-21 | Resumed | Barclays | Overweight |
| Jul-09-21 | Initiated | Seaport Global Securities | Neutral |
| May-19-21 | Initiated | Wells Fargo | Equal Weight |
| Jan-04-21 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Oct-02-20 | Initiated | Bernstein | Mkt Perform |
| Jul-01-20 | Initiated | SVB Leerink | Outperform |
| Jun-16-20 | Downgrade | Cowen | Outperform → Market Perform |
| Jun-05-20 | Initiated | Goldman | Buy |
| Jan-03-20 | Reiterated | JP Morgan | Overweight |
| Oct-18-19 | Initiated | Mizuho | Buy |
| Sep-30-19 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Sep-12-19 | Initiated | Deutsche Bank | Hold |
| Aug-12-19 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Apr-23-19 | Initiated | UBS | Neutral |
| Jan-14-19 | Initiated | Stephens | Overweight |
| Dec-20-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-08-18 | Reiterated | BofA/Merrill | Buy |
| Sep-13-18 | Initiated | Barclays | Overweight |
| Jul-12-18 | Resumed | Morgan Stanley | Overweight |
| Jul-06-18 | Reiterated | Piper Jaffray | Overweight |
| Jun-01-18 | Resumed | Citigroup | Buy |
| Feb-08-18 | Upgrade | Credit Suisse | Neutral → Outperform |
| Feb-08-18 | Reiterated | Leerink Partners | Outperform |
| Jan-12-18 | Upgrade | Jefferies | Hold → Buy |
View All
Humana Inc Stock (HUM) Latest News
Humana Inc. (HUM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
[Form 4] HUMANA INC Insider Trading Activity - Stock Titan
Equity grant boosts Humana (NYSE: HUM) CIO Japan Mehta’s stock and RSUs - Stock Titan
Humana (NYSE: HUM) growth president gets 11,273-share stock grant - Stock Titan
Humana (HUM) CEO awarded 35,633 shares, holds large option grants - Stock Titan
Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders? - Barchart.com
Humana (HUM) HR leader receives 10,485-share equity award - Stock Titan
Director at Humana (HUM) receives 852 RSUs in $200,000 board compensation grant - Stock Titan
Humana (HUM) legal chief awarded 10,318 shares plus option grants - Stock Titan
Humana (HUM) executive adds 9,945 shares and retains major option grants - Stock Titan
Humana trust securities rated BBB- by Fitch - Traders Union
Humana (HUM) Medicare Advantage president granted 8,206 RSUs in award - Stock Titan
Florida Seniors Face High Rates of Poor Mental Health -- A Looming Crisis as State Braces for Aging Population Boom - Business Wire
Major health insurers show signs of recovery – but a key test looms - CNBC
PFA Pension Forsikringsaktieselskab Invests $9.01 Million in Humana Inc. $HUM - MarketBeat
A Look At Humana (HUM) Valuation After Earnings Miss And Lower Full Year Guidance - Yahoo Finance
Humana Inc. stock outperforms competitors on strong trading day - MarketWatch
JPMorgan (JPM) offers $1.901M Humana‑linked auto‑call notes due 2029 - Stock Titan
Strs Ohio Grows Stake in Humana Inc. $HUM - MarketBeat
Should Humana’s (HUM) Lowered 2026 EPS Outlook and Buybacks Prompt a Rethink on Margin Recovery? - simplywall.st
What happens when Humana is the last Medicare Advantage insurer - Modern Healthcare
Comerica Bank Sells 4,526 Shares of Humana Inc. $HUM - MarketBeat
Hussman Strategic Advisors Inc. Invests $2.69 Million in Humana Inc. $HUM - MarketBeat
Danske Bank A S Raises Position in Humana Inc. $HUM - MarketBeat
JPMorgan Large Cap Value Fund's Humana Inc(HUM) Holding History - GuruFocus
Humana Inc. stock underperforms Friday when compared to competitors - MarketWatch
Humana (NYSE:HUM) Given New $214.00 Price Target at JPMorgan Chase & Co. - MarketBeat
TD Cowen Adjusts Price Target on Humana to $211 From $173 - marketscreener.com
Raymond James Adjusts Price Target on Humana to $260 From $230 - marketscreener.com
JPMorgan Adjusts Price Target on Humana to $214 From $180 - marketscreener.com
Humana (NYSE:HUM) Stock Price Expected to Rise, Cantor Fitzgerald Analyst Says - MarketBeat
Mizuho Forecasts Strong Price Appreciation for Humana (NYSE:HUM) Stock - MarketBeat
Humana (NYSE:HUM) Price Target Raised to $195.00 at The Goldman Sachs Group - MarketBeat
Humana (NYSE:HUM) Price Target Raised to $250.00 - MarketBeat
Humana (NYSE:HUM) Stock Price Expected to Rise, Leerink Partners Analyst Says - MarketBeat
Jefferies Financial Group Issues Positive Forecast for Humana (NYSE:HUM) Stock Price - MarketBeat
Humana Investor Suit Largely Survives Dismissal Bid - Law360
FRANKLIN RISING DIVIDENDS VIP FUND's Humana Inc(HUM) Holding History - GuruFocus
HUM Stock Price, Quote & Chart | HUMANA INC (NYSE:HUM) - ChartMill
Humana Pulls Back The Curtain On Planning For 2027 MA Bids - Word & Brown General Agency
Goldman Sachs Adjusts Humana's PT to $195 From $158, Keeps Sell Rating - marketscreener.com
Oppenheimer Adjusts Price Target on Humana to $260 From $250, Maintains Outperform Rating - marketscreener.com
UBS Adjusts Humana Price Target to $262 From $195, Maintains Neutral Rating - marketscreener.com
Humana Q1 2026: Revenue Jumps 23%, But Margin Compression Tells the Real Story - TIKR.com
Jefferies Adjusts Price Target on Humana to $290 From $235 - marketscreener.com
Barclays Adjusts Price Target on Humana to $180 From $176 - marketscreener.com
Guggenheim Adjusts Price Target on Humana to $269 From $252 - marketscreener.com
RBC Raises Price Target on Humana to $246 From $189, Keeps Sector Perform Rating - marketscreener.com
Vanguard reports 9.07M Humana holdings (NYSE: HUM) with 7.55% stake - Stock Titan
Deutsche Bank Aktiengesellschaft Increases Humana (NYSE:HUM) Price Target to $235.00 - MarketBeat
Humana (NYSE:HUM) Price Target Raised to $270.00 at Truist Financial - MarketBeat
Humana Inc Stock (HUM) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):